I expect the FDA / NIH have signaled a lot of interest, in my opinion, in this treatment and treatments like it. I do not believe they will ultimately be rejected. So I have less worry about that, but it would be nice if they got an unusually fast answer from the UK. I think it will ultimately, however, proceed through ILAP in the UK to Project Orbis and receive a relatively speaking decently fast and global set of rolling approvals once they submit their application. But that is my best guess.
Market Data 
Markets 
AI
